Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-31

Clinical Trial Update: 21 Day Comparison of Continuous Insulin Infusion Using HDV Insulin to Standard Insulin in Type 1 Diabetes Mellitus [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing continuous insulin infusion with HDV insulin to standard insulin in type 1 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HDV insulin (HDV insulin)
  • Standard Insulin (insulin)

Snippet

Sponsor: Diasome Pharmaceuticals | Conditions: Type1 Diabetes Mellitus | Phase 2 | Status: COMPLETED